Duff, C
Medicinal plant extracts targeting uv-induced skin damage: molecular mechanisms and therapeutic potential
With enhanced fat metabolism, Lipo-C boosts your energy levels for better daily performance
It takes time for the carnitine levels in your muscle tissues to increase significantly

REDEFINE 2 Trial Type 2 Diabetes with Obesity The companion REDEFINE 2 trial, also published in 2025, enrolled 1,206 adults with type 2 diabetes and obesity or overweight, demonstrating the combinations efficacy in this more metabolically compromised population: Mean weight loss of 13.7% compared to 3.4% with placebo over 68 weeks 73.5% achieved hemoglobin A1c of 6.5% or less compared to 15.9% with placebo Greater proportions reaching multiple weight thresholds including 5%, 10%, 15%, and 20% reduction Significant glycemic improvement with mean A1c reduction demonstrating disease modification potential Favorable metabolic profile changes including improvements in blood pressure and lipids These findings established that the combination maintains substantial efficacy even in patients with the metabolic dysfunction of established type 2 diabetes, a population often showing reduced response to weight-loss interventions

A separate experiment was conducted to confirm the effect of Bd infection using (mBCI) a glutathione fluorescent probe which emits blue fluorescence when conjugated with glutathione (30)